Up-regulation of insulin-like growth factor-I (IGF-I) receptor gene expression in patients with reduced serum IGF-I levels

R. Eshet, H. Werner, B. Klinger, A. Silbergeld, Z. Laron, D. LeRoith, Charles Roberts

Research output: Contribution to journalArticle

43 Citations (Scopus)

Abstract

We have analysed the expression of the IGF-I receptor gene in lymphocytes of patients with low levels of circulating IGF-I (four patients with siolated GH deficiency (IGHD) and one Laron-type dwarf (LTD)) in comparison with a control group exhibiting normal serum IGF-I levels and endocrine profiles. 125I-Labelled IGF-I binding assays were performed on erythrocytes to determine the number of IGF-I binding sites per cell and their dissociation constants. Erythrocytes from patients with IGHD or LTD contained significantly (P = 0.002) more receptors per cell (10.9 ± 3.1 binding sites/cell), with a reduced affinity (K(d) = 0.49 ± 0.05 nM), than erythrocytes from controls (2.0 ± 0.4 sites/cell; K(d) = 0.14 nM). The levels of IGF-I receptor mRNA in circulating lymphocytes were determined by an RNA template-specific reverse transcription/polymerase chain reaction method. There was a statistically significant increase in IGF-I receptor mRNA levels in lymphocytes from patients with LTD or IGHD when compared with controls (3108.1 ± 775.9 vs 576.0 ± 465.7 arbitrary units, P = 0.006). The increased level of IGF-I binding due to increased IGF-I receptor gene expression may represent a compensatory up-regulation process activated in response to the low levels of IGF-I in the circulation of patients with LTD or IGHD.

Original languageEnglish (US)
Pages (from-to)115-120
Number of pages6
JournalJournal of Molecular Endocrinology
Volume10
Issue number2
StatePublished - 1993
Externally publishedYes

Fingerprint

IGF Type 1 Receptor
Insulin-Like Growth Factor I
Up-Regulation
Gene Expression
Serum
Erythrocytes
Lymphocytes
Binding Sites
Messenger RNA
Reverse Transcription
RNA
Polymerase Chain Reaction
Control Groups
Genes

ASJC Scopus subject areas

  • Endocrinology

Cite this

Up-regulation of insulin-like growth factor-I (IGF-I) receptor gene expression in patients with reduced serum IGF-I levels. / Eshet, R.; Werner, H.; Klinger, B.; Silbergeld, A.; Laron, Z.; LeRoith, D.; Roberts, Charles.

In: Journal of Molecular Endocrinology, Vol. 10, No. 2, 1993, p. 115-120.

Research output: Contribution to journalArticle

Eshet, R. ; Werner, H. ; Klinger, B. ; Silbergeld, A. ; Laron, Z. ; LeRoith, D. ; Roberts, Charles. / Up-regulation of insulin-like growth factor-I (IGF-I) receptor gene expression in patients with reduced serum IGF-I levels. In: Journal of Molecular Endocrinology. 1993 ; Vol. 10, No. 2. pp. 115-120.
@article{fa3d7b4e6969488cb603d21c499542c8,
title = "Up-regulation of insulin-like growth factor-I (IGF-I) receptor gene expression in patients with reduced serum IGF-I levels",
abstract = "We have analysed the expression of the IGF-I receptor gene in lymphocytes of patients with low levels of circulating IGF-I (four patients with siolated GH deficiency (IGHD) and one Laron-type dwarf (LTD)) in comparison with a control group exhibiting normal serum IGF-I levels and endocrine profiles. 125I-Labelled IGF-I binding assays were performed on erythrocytes to determine the number of IGF-I binding sites per cell and their dissociation constants. Erythrocytes from patients with IGHD or LTD contained significantly (P = 0.002) more receptors per cell (10.9 ± 3.1 binding sites/cell), with a reduced affinity (K(d) = 0.49 ± 0.05 nM), than erythrocytes from controls (2.0 ± 0.4 sites/cell; K(d) = 0.14 nM). The levels of IGF-I receptor mRNA in circulating lymphocytes were determined by an RNA template-specific reverse transcription/polymerase chain reaction method. There was a statistically significant increase in IGF-I receptor mRNA levels in lymphocytes from patients with LTD or IGHD when compared with controls (3108.1 ± 775.9 vs 576.0 ± 465.7 arbitrary units, P = 0.006). The increased level of IGF-I binding due to increased IGF-I receptor gene expression may represent a compensatory up-regulation process activated in response to the low levels of IGF-I in the circulation of patients with LTD or IGHD.",
author = "R. Eshet and H. Werner and B. Klinger and A. Silbergeld and Z. Laron and D. LeRoith and Charles Roberts",
year = "1993",
language = "English (US)",
volume = "10",
pages = "115--120",
journal = "Journal of Molecular Endocrinology",
issn = "0952-5041",
publisher = "Society for Endocrinology",
number = "2",

}

TY - JOUR

T1 - Up-regulation of insulin-like growth factor-I (IGF-I) receptor gene expression in patients with reduced serum IGF-I levels

AU - Eshet, R.

AU - Werner, H.

AU - Klinger, B.

AU - Silbergeld, A.

AU - Laron, Z.

AU - LeRoith, D.

AU - Roberts, Charles

PY - 1993

Y1 - 1993

N2 - We have analysed the expression of the IGF-I receptor gene in lymphocytes of patients with low levels of circulating IGF-I (four patients with siolated GH deficiency (IGHD) and one Laron-type dwarf (LTD)) in comparison with a control group exhibiting normal serum IGF-I levels and endocrine profiles. 125I-Labelled IGF-I binding assays were performed on erythrocytes to determine the number of IGF-I binding sites per cell and their dissociation constants. Erythrocytes from patients with IGHD or LTD contained significantly (P = 0.002) more receptors per cell (10.9 ± 3.1 binding sites/cell), with a reduced affinity (K(d) = 0.49 ± 0.05 nM), than erythrocytes from controls (2.0 ± 0.4 sites/cell; K(d) = 0.14 nM). The levels of IGF-I receptor mRNA in circulating lymphocytes were determined by an RNA template-specific reverse transcription/polymerase chain reaction method. There was a statistically significant increase in IGF-I receptor mRNA levels in lymphocytes from patients with LTD or IGHD when compared with controls (3108.1 ± 775.9 vs 576.0 ± 465.7 arbitrary units, P = 0.006). The increased level of IGF-I binding due to increased IGF-I receptor gene expression may represent a compensatory up-regulation process activated in response to the low levels of IGF-I in the circulation of patients with LTD or IGHD.

AB - We have analysed the expression of the IGF-I receptor gene in lymphocytes of patients with low levels of circulating IGF-I (four patients with siolated GH deficiency (IGHD) and one Laron-type dwarf (LTD)) in comparison with a control group exhibiting normal serum IGF-I levels and endocrine profiles. 125I-Labelled IGF-I binding assays were performed on erythrocytes to determine the number of IGF-I binding sites per cell and their dissociation constants. Erythrocytes from patients with IGHD or LTD contained significantly (P = 0.002) more receptors per cell (10.9 ± 3.1 binding sites/cell), with a reduced affinity (K(d) = 0.49 ± 0.05 nM), than erythrocytes from controls (2.0 ± 0.4 sites/cell; K(d) = 0.14 nM). The levels of IGF-I receptor mRNA in circulating lymphocytes were determined by an RNA template-specific reverse transcription/polymerase chain reaction method. There was a statistically significant increase in IGF-I receptor mRNA levels in lymphocytes from patients with LTD or IGHD when compared with controls (3108.1 ± 775.9 vs 576.0 ± 465.7 arbitrary units, P = 0.006). The increased level of IGF-I binding due to increased IGF-I receptor gene expression may represent a compensatory up-regulation process activated in response to the low levels of IGF-I in the circulation of patients with LTD or IGHD.

UR - http://www.scopus.com/inward/record.url?scp=0027537988&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027537988&partnerID=8YFLogxK

M3 - Article

C2 - 8484860

AN - SCOPUS:0027537988

VL - 10

SP - 115

EP - 120

JO - Journal of Molecular Endocrinology

JF - Journal of Molecular Endocrinology

SN - 0952-5041

IS - 2

ER -